---
title: "Radotinib - Chronic myeloid leukemia"
sidebar: mydoc_sidebar
permalink: db12323-mesh-d015464-1.html
toc: false 
---


Path ID: `DB12323_MESH_D015464_1`
{% include image.html url="images/db12323-mesh-d015464-1.png" file="db12323-mesh-d015464-1.png" alt="db12323-mesh-d015464-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C000606751 | Radotinib | Drug |
| UniProt:P00519 | Tyrosine-protein kinase ABL1 | Protein |
| MESH:D016044 | Fusion Proteins, bcr-abl | Protein |
| MESH:D017479 | Receptors, Platelet-Derived Growth Factor | GeneFamily |
| GO:0004713 | protein tyrosine kinase activity | MolecularActivity |
| GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | BiologicalProcess |
| GO:0008283 | cell population proliferation | BiologicalProcess |
| GO:0048008 | platelet-derived growth factor receptor signaling pathway | BiologicalProcess |
| GO:0001525 | angiogenesis | BiologicalProcess |
| MESH:D015464 | Chronic myeloid leukemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Radotinib | DECREASES ACTIVITY OF | Tyrosine-Protein Kinase Abl1 |
| Radotinib | DECREASES ACTIVITY OF | Fusion Proteins, Bcr-Abl |
| Radotinib | DECREASES ACTIVITY OF | Receptors, Platelet-Derived Growth Factor |
| Tyrosine-Protein Kinase Abl1 | POSITIVELY REGULATES | Protein Tyrosine Kinase Activity |
| Fusion Proteins, Bcr-Abl | POSITIVELY REGULATES | Protein Tyrosine Kinase Activity |
| Receptors, Platelet-Derived Growth Factor | POSITIVELY REGULATES | Protein Tyrosine Kinase Activity |
| Tyrosine-Protein Kinase Abl1 | POSITIVELY CORRELATED WITH | Platelet-Derived Growth Factor Receptor-Beta Signaling Pathway |
| Fusion Proteins, Bcr-Abl | POSITIVELY CORRELATED WITH | Platelet-Derived Growth Factor Receptor-Beta Signaling Pathway |
| Receptors, Platelet-Derived Growth Factor | POSITIVELY CORRELATED WITH | Platelet-Derived Growth Factor Receptor Signaling Pathway |
| Platelet-Derived Growth Factor Receptor-Beta Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Platelet-Derived Growth Factor Receptor Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Protein Tyrosine Kinase Activity | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Platelet-Derived Growth Factor Receptor-Beta Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Platelet-Derived Growth Factor Receptor Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Protein Tyrosine Kinase Activity | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Platelet-Derived Growth Factor Receptor-Beta Signaling Pathway | POSITIVELY CORRELATED WITH | Angiogenesis |
| Platelet-Derived Growth Factor Receptor Signaling Pathway | POSITIVELY CORRELATED WITH | Angiogenesis |
| Protein Tyrosine Kinase Activity | POSITIVELY CORRELATED WITH | Angiogenesis |
| Angiogenesis | POSITIVELY CORRELATED WITH | Chronic Myeloid Leukemia |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Chronic Myeloid Leukemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB12323#mechanism-of-action](https://go.drugbank.com/drugs/DB12323#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Radotinib](https://en.wikipedia.org/wiki/Radotinib)
  - [https://drugcentral.org/drugcard/5188](https://drugcentral.org/drugcard/5188)
